Microenvironment and Tumor Heterogeneity as Pharmacological Targets in Precision Oncology

Microenvironment and Tumor Heterogeneity as Pharmacological Targets in Precision Oncology

Tumor diseases are characterized by high interindividual and intratumoral heterogeneity (ITH). The development and progression of neoplasms outline complex networks of extracellular and cellular signals that have yet to be fully elucidated. This narrative review provides a comprehensive overview of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Stelvio Tonello, Roberta Rolla, Paolo Amedeo Tillio, Pier Paolo Sainaghi, Donato Colangelo
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Pharmaceuticals
Subjects:	precision medicine intratumor heterogeneity tumor microenvironment molecular targeted pharmacological therapy
Online Access:	https://www.mdpi.com/1424-8247/18/6/915
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Decoding breast cancer heterogeneity: a novel three-gene signature links intratumoral heterogeneity with tumor microenvironment and patient outcomes
by: Fangfang Zhu
Published: (2025-07-01)

Spatial Heterogeneity of Intratumoral Microbiota: A New Frontier in Cancer Immunotherapy Resistance
by: Qiwen Tan, et al.
Published: (2025-05-01)

Extracellular Traps in Inflammation: Pathways and Therapeutic Targets
by: Stelvio Tonello, et al.
Published: (2025-04-01)

Tumor Niche Influences the Activity and Delivery of Anticancer Drugs: Pharmacology Meets Chemistry
by: Mauro Ravera, et al.
Published: (2025-07-01)

Intratumor heterogeneity related signature for clinical outcome and immunotherapy advantages in lung adenocarcinoma
by: Yanhua Zuo, et al.
Published: (2025-03-01)

Tumor-resident Malassezia can promote hepatocellular carcinoma development by downregulating bile acid synthesis and modulating tumor microenvironment
by: Weixi Shen, et al.
Published: (2025-04-01)

Machine learning based intratumor heterogeneity related signature for prognosis and drug sensitivity in breast cancer
by: Hongcai Chen, et al.
Published: (2025-03-01)

Tumor-colonizing Pseudoalteromonas elyakovii metabolically reprograms the tumor microenvironment and promotes breast ductal carcinoma
by: Shuyan Liu, et al.
Published: (2025-05-01)

Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy
by: Jinhe Zhang, et al.
Published: (2025-08-01)

CT-based quantification of intratumoral heterogeneity for predicting distant metastasis in retroperitoneal sarcoma
by: Jun Xu, et al.
Published: (2025-05-01)

Tumor microenvironment signatures enhances lung adenocarcinoma prognosis prediction: Implication of intratumoral microbiota
by: Fei Zhao, et al.
Published: (2025-08-01)

Circulating tumor DNA detection (liquid biopsy): prospects in oncology
by: N. V. Zhukov, et al.
Published: (2015-01-01)

Intratumor morphologic and molecular genetic heterogeneity in astrocytomas of different grade of malignancy in the material from the first operation
by: D. E. Matsko, et al.
Published: (2022-01-01)

scPharm: Identifying Pharmacological Subpopulations of Single Cells for Precision Medicine in Cancers
by: Peng Tian, et al.
Published: (2025-01-01)

Integrating bulk and single-cell RNA sequencing reveals intratumor heterogeneity phenotypes and immune infiltration in pancreatic cancer
by: Li Zhao, et al.
Published: (2025-07-01)

Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma
by: Shaoming Song, et al.
Published: (2025-03-01)

Deciphering genomic complexity: Understanding intratumor heterogeneity, clonal evolution, and therapeutic vulnerabilities in oral squamous cell carcinoma
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Integrated spatial multi‐omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression
by: Feng Zhao, et al.
Published: (2025-03-01)

Precise Pharmacology /
by: Nathan,Muyinda
Published: (2016)

Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma
by: Keiichiro Kitahama, et al.
Published: (2025-08-01)

Fusobacterium nucleatum Enrichment in Colorectal Tumor Tissue: Associations With Tumor Characteristics and Survival Outcomes
by: Amanda I. Phipps, et al.
Published: (2025-01-01)

The role of CD47 in immune escape of colon cancer and its correlation with heterogeneity of tumor immune microenvironment
by: Qiu-Si Tian, et al.
Published: (2024-12-01)

Single-cell transcriptomics link gene expression signatures to clinicopathological features of gonadotroph and lactotroph PitNET
by: T. Elise Potthoff, et al.
Published: (2024-11-01)

PROGNOSTIC SIGNIFICANCE OF THE EPITHELIAL-MESENCHYMAL TRANSITION MARKERS AND MORPHOLOGICAL CHARACTERISTICS OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS IN THE DEVELOPMENT OF LYMPHOGENOUS METASTASES
by: V. A. Bychkov, et al.
Published: (2020-01-01)

Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
by: Remya P. G. Ramesh, et al.
Published: (2025-03-01)

The intratumor microbiota and thyroid cancer: a review
by: Shan Liu, et al.
Published: (2025-06-01)

Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type
by: Yi Gao, et al.
Published: (2025-04-01)

Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translation
by: Aline Talhouk, et al.
Published: (2025-01-01)

Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models
by: Soon-Chan Kim, et al.
Published: (2025-05-01)

Quantifying intratumoral heterogeneity within sub-regions to predict high-grade patterns in clinical stage I solid lung adenocarcinoma
by: Zhichao Zuo, et al.
Published: (2025-01-01)

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product
by: David Willoughby, et al.
Published: (2025-03-01)

A subcentimeter duodenal neuroendocrine neoplasm with a liver metastasis upgraded to G3: a case report
by: Tomoya Kitada, et al.
Published: (2021-03-01)

Research Progress on Regulation of Tumor-Associated Macrophages Polarization by Intratumoral Microorganisms in Pancreatic Cancer
by: Yaxian YAN, et al.
Published: (2025-03-01)

Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation
by: Xinxin Chen, et al.
Published: (2025-05-01)

Heterogeneity and clonal evolution of colorectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2017-04-01)

Exploring Neutrophil Heterogeneity and Plasticity in Health and Disease
by: Conny Gysemans, et al.
Published: (2025-03-01)

Value of MRI radiomics based on intratumoral and peritumoral heterogeneity in predicting spatial patterns of locally recurrent high-grade gliomas
by: WANG Hanwei, et al.
Published: (2025-07-01)

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
by: Michael Heming, et al.
Published: (2022-09-01)

Characteristics of inflammatory reactions in the tumor microenvironment of head and neck squamous cell carcinoma
by: V. A. Bychkov, et al.
Published: (2019-01-01)

An Explainable Graph Neural Framework to Identify Cancer‐Associated Intratumoral Microbial Communities
by: Zhaoqian Liu, et al.
Published: (2024-11-01)